To include your compound in the COVID-19 Resource Center, submit it here.

OrbiMed's Asia 2.0

Why OrbiMed's new $325M Asia fund lacks European LPs

OrbiMed Advisors last week closed its second Asia-focused healthcare fund, OrbiMed Asia Partners II LP, at $325 million - above its $300 million target based on strong interest from the U.S. and Asia. But the

Read the full 354 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers